文献速递白血病

与NOX2相关的29基因特征可区分急性髓系白血病的预后与生存

A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival.
PubMed 文献 · Am J Hematol · 2022-02-08

研究聚焦急性髓系白血病(AML)中活性氧(ROS)产生与代谢,发现AML患者NOX2复合物四个成员(含CYBB)表达下调,并筛选出28个与CYBB表达相关的代谢基因,构成29基因特征(29G)。29G在6个AML队列共1821例中总体准确率为85%、78%、80%、75%、59%和83%,低表达指数组总生存(OS)高于高表达指数组,并在三个数据集共1069例中证实。

要点

  • AML患者NOX2复合物四个成员(含编码NOX2的CYBB)表达下调。
  • 29G在6个AML队列共1821例中总体准确率为85%、78%、80%、75%、59%和83%。
  • 低29G表达指数组OS高于高表达指数组,并在三个数据集共1069例中证实。

核心结论

  • 29G基因特征可用于AML分类和总生存预测,结果提示NOX和代谢可作为AML的潜在治疗靶点。

研究设计与样本

  • 研究比较AML与健康样本的基因表达,分析941个代谢相关基因,构建29基因特征(29G),并在6个AML队列数据集共1821例中验证。

主要发现

  • AML与健康样本基因表达两两比较显示NOX2复合物四个成员(含CYBB)在AML患者中下调。
  • 941个代谢相关基因中28个基因表达与CYBB相关,与CYBB共同构成29G。
  • 29G在6个AML队列数据集共1821例中总体准确率为85%、78%、80%、75%、59%和83%。
  • 低29G表达指数组总生存高于高29G表达指数组,并在三个数据集共1069例中证实。
  • 29G可将中危预后患者分为四个总生存不同的聚类。

关键数值与推荐

  • 29G由28个与CYBB表达相关的代谢基因和CYBB构成。
  • 6个AML队列数据集共1821例的总体准确率分别为85%、78%、80%、75%、59%和83%。
  • 三个数据集共1069例中低29G表达指数组总生存高于高表达指数组。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The molecular complexity displayed in acute myeloid leukemia (AML) hinders patient stratification and treatment decisions. Previous studies support the utility of using specific gene panels for this purpose. Focusing on two salient features of AML, the production of reactive oxygen species (ROS) by NADPH oxidases (NOX) and metabolism, we aimed to identify a gene panel that could improve patient stratification. A pairwise comparison of AML versus healthy gene expression revealed the downregulation of four members of the NOX2 complex including CYBB (coding for NOX2) in AML patients. We analyzed the expression of 941 genes related to metabolism and found 28 genes with expression correlated to CYBB. This panel of 29 genes (29G) effectively divides AML samples according to their prognostic group. The robustness of 29G was confirmed by 6 AML cohort datasets with a total of 1821 patients (overall accuracies of 85%, 78%, 80%, 75%, 59% and 83%). An expression index (EI) was developed according to the expression of the selected discriminatory genes. Overall Survival (OS) was higher for low 29G expression index patients than for the high 29G expression index group, which was confirmed in three different datasets with a total of 1069 patients. Moreover, 29G can dissect intermediate-prognosis patients in four clusters with different OS, which could improve the current AML stratification scheme. In summary, we have found a gene signature (29G) that can be used for AML classification and for OS prediction. Our results confirm NOX and metabolism as suitable therapeutic targets in AML.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Ijurko C, González-García N, Galindo-Villardón P, et al. A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival. Am J Hematol. 2022. PMID: 35073432. doi:10.1002/ajh.26477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。